Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are three profitable companies that don’t make the cut and some better opportunities instead.
Levi's (LEVI)
Trailing 12-Month GAAP Operating Margin: 10.6%
Credited for inventing the first pair of blue jeans in 1873, Levi's (NYSE: LEVI) is an apparel company renowned for its iconic denim products and classic American style.
Why Are We Bearish on LEVI?
- Weak constant currency growth over the past two years indicates challenges in maintaining its market share
- Projected 6.4 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
At $24.54 per share, Levi's trades at 15.1x forward P/E. If you’re considering LEVI for your portfolio, see our FREE research report to learn more.
Timken (TKR)
Trailing 12-Month GAAP Operating Margin: 10.5%
Established after the founder noticed the difficulty freight wagons had making sharp turns, Timken (NYSE: TKR) is a provider of industrial parts used across various sectors.
Why Do We Think TKR Will Underperform?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Earnings per share have dipped by 2.5% annually over the past two years, which is concerning because stock prices follow EPS over the long term
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Timken is trading at $130.75 per share, or 19.6x forward P/E. To fully understand why you should be careful with TKR, check out our full research report (it’s free).
Option Care Health (OPCH)
Trailing 12-Month GAAP Operating Margin: 5.9%
With a nationwide network of 177 locations serving 43 states and a team of over 4,500 clinicians, Option Care Health (NASDAQ: OPCH) is the largest independent provider of home and alternate site infusion services, delivering medications and clinical support to patients across the United States.
Why Is OPCH Not Exciting?
- Estimated sales growth of 4.3% for the next 12 months implies demand will slow from its two-year trend
- Free cash flow margin was stuck in limbo over the last five years
- ROIC hasn’t moved, making investors question whether its recent investments can increase profitability
Option Care Health’s stock price of $23.79 implies a valuation ratio of 12x forward P/E. Read our free research report to see why you should think twice about including OPCH in your portfolio.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
